• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

憩室病患者结肠黏膜中……的丰度

Abundance of in the colon mucosa in diverticular disease.

作者信息

Linninge Caroline, Roth Bodil, Erlanson-Albertsson Charlotte, Molin Göran, Toth Ervin, Ohlsson Bodil

机构信息

Department of Food Technology, Engineering and Nutrition, Lund University, Lund S-223 63, Sweden.

Department of Internal Medicine, Skåne University Hospital, Lund University, Malmö S-205 02, Sweden.

出版信息

World J Gastrointest Pathophysiol. 2018 Feb 15;9(1):18-27. doi: 10.4291/wjgp.v9.i1.18.

DOI:10.4291/wjgp.v9.i1.18
PMID:29487763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5823699/
Abstract

AIM

To compare gut bacterial diversity and amount of in colonic mucosa between patients with and without diverticular disease (DD).

METHODS

Patients in a stable clinical condition with planned elective colonoscopy were included. Blood samples and colon mucosa biopsies were collected at the colonoscopy. Study questionnaires including questions about gastrointestinal symptoms were completed by the patients and physicians. DNA from mucosa samples was isolated and the amount of was estimated using PCR assay. Terminal restriction fragment length polymorphism was applied to assess microbial diversity. Diversity was estimated by calculations of richness (number of terminal restriction fragments) and Shannon-Wiener and Simpson's indices.

RESULTS

A total of 51 patients were included, 16 patients with DD [68 (62-76) years] and 35 controls [62 (40-74) years] without any diverticula. Patients with DD had significantly higher levels of than those without DD ( = 0.043), and there was an inverse relationship between the amount of and the Simpson's index (rs = -0.361, = 0.033) and the Shannon-Wiener index (rs = -0.299, = 0.081). The Simpson's index ( = 0.383), Shannon-Wiener index ( = 0.401) or number of restrictions fragments ( = 0.776) did not differ between DD and controls. The majority of patients experienced gastrointestinal symptoms, and 22 patients (43.1%) fulfilled the criteria for irritable bowel syndrome, with no difference between the groups ( = 0.212). Demography, socioeconomic status, lifestyle habits, inflammatory biomarkers, or symptoms were not related to the amount of or bacterial diversity.

CONCLUSION

Patients with DD had higher amount of in the colon mucosa compared to patients without diverticula.

摘要

目的

比较憩室病(DD)患者与无憩室病患者结肠黏膜中的肠道细菌多样性及[此处原文缺失具体物质,无法准确翻译]数量。

方法

纳入临床状况稳定且计划进行择期结肠镜检查的患者。在结肠镜检查时采集血样和结肠黏膜活检样本。患者和医生完成包括胃肠道症状问题的研究问卷。从黏膜样本中分离DNA,并使用聚合酶链反应(PCR)测定法估计[此处原文缺失具体物质,无法准确翻译]数量。应用末端限制性片段长度多态性来评估微生物多样性。通过计算丰富度(末端限制性片段数量)、香农 - 威纳指数和辛普森指数来估计多样性。

结果

共纳入51例患者,16例DD患者[68(62 - 76)岁]和35例无任何憩室的对照者[62(40 - 74)岁]。DD患者的[此处原文缺失具体物质,无法准确翻译]水平显著高于无DD患者(= 0.043),且[此处原文缺失具体物质]数量与辛普森指数(rs = -0.361,= 0.033)和香农 - 威纳指数(rs = -0.299,= 0.081)呈负相关。DD患者与对照者之间的辛普森指数(= 0.383)、香农 - 威纳指数(= 0.401)或限制性片段数量(= 0.776)无差异。大多数患者有胃肠道症状,22例患者(43.1%)符合肠易激综合征标准,两组之间无差异(= 0.212)。人口统计学、社会经济状况、生活习惯、炎症生物标志物或症状与[此处原文缺失具体物质,无法准确翻译]数量或细菌多样性无关。

结论

与无憩室患者相比,DD患者结肠黏膜中的[此处原文缺失具体物质,无法准确翻译]数量更高。

相似文献

1
Abundance of in the colon mucosa in diverticular disease.憩室病患者结肠黏膜中……的丰度
World J Gastrointest Pathophysiol. 2018 Feb 15;9(1):18-27. doi: 10.4291/wjgp.v9.i1.18.
2
[Terminal-restriction fragment length polymorphism analysis of diversity of mucosa-associated microbiota in patients with Crohn's disease].[克罗恩病患者黏膜相关微生物群多样性的末端限制性片段长度多态性分析]
Zhonghua Yi Xue Za Zhi. 2013 Sep 24;93(36):2884-9.
3
Probiotics and Diverticular Disease: Evidence-based?益生菌与憩室病:基于证据吗?
J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S159-S160. doi: 10.1097/MCG.0000000000000684.
4
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.健康、憩室病、肠易激综合征及炎症性肠病中的肠道微生物群:是时候寻找胃肠道疾病的微生物标志物了。
Dig Dis. 2018;36(1):56-65. doi: 10.1159/000477205. Epub 2017 Jul 7.
5
Microbiota of the Colonic Diverticula in the Complicated Form of Diverticulitis: A Case Report.复杂性憩室炎中结肠憩室的微生物群:一例报告
Life (Basel). 2022 Dec 16;12(12):2129. doi: 10.3390/life12122129.
6
Association of colonic diverticular disease and irritable bowel syndrome in Thai patients.泰国患者结肠憩室病与肠易激综合征的关联
J Med Assoc Thai. 2014 Nov;97 Suppl 11:S18-24.
7
Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition.在患有憩室病的结肠中,产生血清素的细胞数量增加可能表明其参与了该病症的病理生理学过程。
Int J Colorectal Dis. 2007 Jun;22(6):643-9. doi: 10.1007/s00384-006-0216-4. Epub 2006 Nov 4.
8
Investigating Unused Tools for the Animal Behavioral Diversity Toolkit.探索动物行为多样性工具包中未使用的工具。
Animals (Basel). 2022 Oct 30;12(21):2984. doi: 10.3390/ani12212984.
9
[Diversity analysis of luminal and mucosa-associated microbial communities in obese mice].[肥胖小鼠管腔和黏膜相关微生物群落的多样性分析]
Zhonghua Nei Ke Za Zhi. 2018 Oct 1;57(10):743-748. doi: 10.3760/cma.j.issn.0578-1426.2018.10.009.
10
Utilization of High-frequency Mini Probe Ultrasound in the Assessment of Colonic Wall Thickness in Patients With Diverticular Disease: A Feasibility Study.高频微型探头超声在憩室病患者结肠壁厚度评估中的应用:一项可行性研究。
Surg Laparosc Endosc Percutan Tech. 2015 Jun;25(3):205-8. doi: 10.1097/SLE.0000000000000152.

引用本文的文献

1
Safety and efficacy of faecal microbiota transplantation in patients with acute uncomplicated diverticulitis: study protocol for a randomised placebo-controlled trial.粪便微生物群移植治疗急性非复杂性憩室炎患者的安全性和有效性:一项随机安慰剂对照试验的研究方案
Therap Adv Gastroenterol. 2025 Jan 2;18:17562848241309868. doi: 10.1177/17562848241309868. eCollection 2025.
2
Genetic, epigenetic and environmental factors in diverticular disease: systematic review.憩室病的遗传、表观遗传和环境因素:系统综述。
BJS Open. 2024 May 8;8(3). doi: 10.1093/bjsopen/zrae032.
3
Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study.利福昔明的生态效应与症状性单纯性憩室病腹痛减轻有关:来自观察性队列研究的结果。
BMC Gastroenterol. 2023 Mar 23;23(1):82. doi: 10.1186/s12876-023-02690-x.
4
Does Alteration of the Microbiome Cause Diverticular Disease?微生物群的改变会导致憩室病吗?
Clin Colon Rectal Surg. 2023 Jan 17;36(2):146-150. doi: 10.1055/s-0042-1760676. eCollection 2023 Mar.
5
Does the microbiome play a role in the pathogenesis of colonic diverticular disease? A systematic review.肠道微生物组在结肠憩室病发病机制中的作用?系统评价。
J Gastroenterol Hepatol. 2023 Jul;38(7):1028-1039. doi: 10.1111/jgh.16142. Epub 2023 Feb 26.
6
Microbiota Composition in Diverticular Disease: Implications for Therapy.肠憩室病中的微生物群落组成:治疗的启示。
Int J Mol Sci. 2022 Nov 26;23(23):14799. doi: 10.3390/ijms232314799.
7
Gut Microbiota Association with Diverticular Disease Pathogenesis and Progression: A Systematic Review.肠道微生物群与憩室病发病机制和进展的关联:系统评价。
Dig Dis Sci. 2023 Mar;68(3):913-921. doi: 10.1007/s10620-022-07600-x. Epub 2022 Jul 7.
8
A Comprehensive Evaluation of Primer Sets for Analysis of Host-Associated Microbiota.用于分析宿主相关微生物群的引物组的综合评估
Pathogens. 2021 Dec 23;11(1):17. doi: 10.3390/pathogens11010017.
9
Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects.受限的T细胞受体β链互补决定区3克隆型与急性乙型肝炎已愈患者相关。
BMC Infect Dis. 2021 Jan 23;21(1):111. doi: 10.1186/s12879-021-05816-2.
10
Role of Inflammation in Pathophysiology of Colonic Disease: An Update.炎症在结肠疾病发病机制中的作用:最新进展。
Int J Mol Sci. 2020 Jul 3;21(13):4748. doi: 10.3390/ijms21134748.

本文引用的文献

1
Microbial metabolites in health and disease: Navigating the unknown in search of function.健康与疾病中的微生物代谢产物:探索未知以寻找其功能
J Biol Chem. 2017 May 26;292(21):8553-8559. doi: 10.1074/jbc.R116.752899. Epub 2017 Apr 7.
2
Dietary green-plant thylakoids decrease gastric emptying and gut transit, promote changes in the gut microbial flora, but does not cause steatorrhea.食用绿色植物类囊体可减缓胃排空和肠道转运,促进肠道微生物群的变化,但不会导致脂肪泻。
Nutr Metab (Lond). 2016 Oct 12;13:67. doi: 10.1186/s12986-016-0128-4. eCollection 2016.
3
Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon.有症状的非复杂性结肠憩室病患者粪便微生物群和粪便代谢组的评估
J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S9-S12. doi: 10.1097/MCG.0000000000000626.
4
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease.复杂性憩室病患者的肠道微生物群、代谢组和免疫特征。
Gut. 2017 Jul;66(7):1252-1261. doi: 10.1136/gutjnl-2016-312377. Epub 2016 Sep 12.
5
Current best practice for disease activity assessment in IBD.目前用于评估 IBD 疾病活动的最佳实践。
Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):567-79. doi: 10.1038/nrgastro.2016.128. Epub 2016 Sep 1.
6
Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis.肠易激综合征患者肠道微生物群的改变:一项系统评价和荟萃分析。
J Gastroenterol Hepatol. 2017 Jan;32(1):28-38. doi: 10.1111/jgh.13471.
7
Gastroduodenal Disorders.胃十二指肠疾病。
Gastroenterology. 2016 May;150(6):1380-92. doi: 10.1053/j.gastro.2016.02.011.
8
Bowel Disorders.肠道疾病
Gastroenterology. 2016 Feb 18. doi: 10.1053/j.gastro.2016.02.031.
9
The human gut microbiome and its dysfunctions through the meta-omics prism.通过元组学视角看人类肠道微生物组及其功能障碍
Ann N Y Acad Sci. 2016 May;1372(1):9-19. doi: 10.1111/nyas.13033. Epub 2016 Mar 4.
10
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.肠道微生物群在肠易激综合征中的作用:新的治疗策略。
World J Gastroenterol. 2016 Feb 21;22(7):2219-41. doi: 10.3748/wjg.v22.i7.2219.